Updated Guidelines for Management of High Blood Pressure: Recommendations, Review, and Responsibility | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
Editorial
February 5, 2014

Updated Guidelines for Management of High Blood Pressure: Recommendations, Review, and Responsibility

Author Affiliations
  • 1Dr Bauchner is Editor in Chief, Dr Fontanarosa is Executive Editor, and Dr Golub is Deputy Editor, JAMA
JAMA. 2014;311(5):477-478. doi:10.1001/jama.2013.284432

Hypertension is a common major risk factor for cardiovascular disease and stroke. It is estimated that in 2010, nearly 78 million US adults (aged ≥20 years) had high blood pressure, but in approximately 50%, hypertension was not adequately controlled.1 Most patients with hypertension are treated by primary care physicians; treatment is effective and includes both lifestyle interventions and relatively inexpensive medications. The importance of detecting and treating hypertension is well-recognized by professional societies and federal agencies.

In their article published in JAMA, the panel members appointed to the Eighth Joint National Committee (JNC 8) report their Evidence-Based Guideline for the Management of High Blood Pressure in Adults.2 This guideline has been long-awaited and much anticipated, with the last revision of the blood pressure guidelines, the JNC 7 report, having been published in JAMA in 2003.3 An update of this decade-old guideline is overdue, considering that about half of the major recommendations in guidelines become outdated in approximately 6 years.4

×